Supporting virtual clinical trials with laboratory services that focus on easing patient and site burden by way of innovative self-collection technology.
Hybrid and decentralized clinical trials (DCTs) are fast becoming the norm, but they often involve multiple vendors and service providers, presenting sponsors and CROs with new considerations on the...
With recent advancements in the self-collection of blood allowing trial participants to provide blood specimen for lab testing from the comfort of their home, Q2 Solutions’ Chuck Drucker recently...
You feel like a ball of anxiety from the beginning to the end of your clinical trials. You have so many competing priorities that you don’t have time to learn new technology. You want to build...
NAR Cancer article, with contributions from Wendell Jones, PhD, Q2 Solutions GenomicsUterine serous carcinoma (USC), an aggressive variant of endometrial cancer representing approximately 10% of...
With a renewed interest in vaccine research and development (R&D), stakeholders across the industry are rethinking their approach to the field. Biopharmaceutical companies have growing numbers of...
Stakeholders from across the industry, including biopharmaceutical companies, governments, and non-profit organizations, are rethinking their pandemic readiness in light of the COVID-19 pandemic,...